With a year-to-date decline in share price, along with strong hedge fund interest, Danaher Corporation (NYSE:DHR) secures a ...

The S&P 500 notched three new record highs this week, but the rally fell short on Friday. Click here to read more.

Global X SuperDividend ETF empirical performance consistently underperforms peers. See why SDIV's high yield may not deliver ...

The S&P 500 has been a cornerstone of wealth-building for decades, delivering average returns of about 10% annually through ...

The initial headline number showed that the often overlooked gauge, which measures prices paid to domestic producers, rose by 0.9% in July. That was the fastest pace in three years, and much higher ...

The initial headline number showed that the often overlooked gauge, which measures prices paid to domestic producers, rose by 0.9% in July. That was the fastest pace in three years, and much higher ...

Investing.com -- Wells Fargo has initiated coverage on ArcelorMittal SA with an “equal weight” rating and a price target of ...

Barclays upgraded Allegion (ALLE) to Equal Weight from Underweight with a price target of $163, up from $156. The firm sees less downside risk ...

Barclays analyst Julian Mitchell downgraded Fortive (FTV) to Equal Weight from Overweight with a price target of $54, down from $58. The company’s ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

Morgan Stanley added that ELS is positioned for steady growth, with steady mid-single digit gains from internal operations ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.